Mark Sabag, See "Remarks" at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 355,252 shares at $16.25 ($5.8M) on 2025-02-12, disclosed to the SEC on 2025-02-14.
Seasonal sale ($5.8M) by See "Remarks" — this insider has traded TEVA in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.25 | 177,626 | $2.9M | 50.0% |
| 2 | $16.25 | 177,626 | $2.9M | 50.0% |
| Total | $16.25 avg | 355,252 | $5.8M | 100% |
| Filing → |
| TEVA | SELL | 2025-12-11 | $9.0M | — | Filing → |
| TEVA | SELL | 2025-05-12 | $12.2M | — | Filing → |
| TEVA | SELL | 2024-03-07 | $1.4M | — | Filing → |